(Date:7/4/2009)...dgets are tight, experts say, health and fitness n...ealthDay News) -- Most people are cutting back in ...d make do with less. But can you cut back when it ...s say you can -- if you,re smart about it. There a...g healthily, staying physically fit and receiving ...
(Date:7/3/2009)... July 3 Ramsy Darwish knows what i...ation. In a recent story called America,s "Other...h CNN,s Rick Sanchez, Ramsy shared his story of ad...ending up at the Narconon Freedom Center drug ...o 72dpi: Send2Press.com/mediaboom/09-0703-Narcon...
(Date:7/3/2009)...express hope that finding will lead to treatments,...- U.S. researchers say they,ve found a major cellu...ed lung cancer. , When caught early, lung cance...ected until the disease is well advanced. Though d..., the disease often springs back more virulent tha...
(Date:7/3/2009)... Eva,s Village, ( http://www.EvasVill...harity, Seeks Buyers for 35mm Michael Jackson Film... Paterson, NJ (PRWEB) July 3, ... ), a non-profit New Jersey anti-poverty charity, ...m print of Michael Jackson,s "Thriller" ...
Breaking Medicine News(10 mins):Health News:Living Healthily on Less 2Health News:Living Healthily on Less 3Health News:Living Healthily on Less 4Health News:Narconon Graduate Successfully Recovers From Prescription Drug Abuse 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5(Date:6/30/2009)...., June 30 Cephalon, Inc...bmitted a supplemental New Drug Application (sNDA)...questing approval of NUVIGIL(R) (armodafinil) Tabl...ess in patients with excessive sleepiness associat...travel. Jet lag disorder is an acute condition th...
(Date:6/29/2009)...ajor abdominal surgery patients achieved primary a..., June 29 AcelRx Pharmaceuticals, ...ond Phase 2 clinical study evaluating the safety a...for the management of acute post-operative pain in...alization. Compared to placebo, patients receiving...
(Date:6/28/2009)...NHAM, England and TOKYO, June 29 ,... Companies , Sosei Group Corporation ("Sose...c ("Vectura"; LSE: VEC) announce the commencement ...VA237, a once-daily, long-acting muscarinic,antag...ive pulmonary disease,(COPD). NVA237 is a dry pow...
(Date:6/26/2009)...pinion Recommends Approval of New Anti-TNF Therapy...TM) Autoinjector , , HORSHAM, Pa. and KENILWORT...r Ortho Biotech Inc. and Schering-Plough Corporati...ee for Medicinal Products for Human Use (CHMP) of ...itive opinion recommending the approval of SIMPONI...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Vermont Surgeon Implants First Accommodating Crystalens in Russia 9146 1Vermont Surgeon Implants First Accommodating Crystalens in Russia 9146 2PLC Systems Updates Common Stock Listing Status 29620 1PLC Systems Updates Common Stock Listing Status 29620 2Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 1Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 2Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 3Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures 29614 1Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures 29614 2...E)--Jun 27, 2007 - Gentium S.p.A. (Nasdaq:,GENT) a...clinical,data that support the safety, activity, s...otide in combination with anticancer,therapy in mu...date,from the Company,s ongoing Phase I/II clinica...ultiple myeloma with Defibrotide in,combination wi...
...WIRE)--Jun 28, 2007 - Accentia,Biopharmaceuticals,...27 at the Jefferies Healthcare Conference that its... fifty patients in the,Fast-Tracked Phase 3 clinic...ation, has demonstrated substantial improvement in...s of chronic,sinusitis, and substantial improvemen...
Other Medicine Technology:Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis 2Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis 3Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis 4Double round silicone drain with trocar, 49 in. long, with 12.25 in. (30.5 cm) hole pattern
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Used for cholangiography and bile stone removal using fluoroscopy. Dual lumen catheter design allows concomitant fluoroscopic biliary imaging and wire basket placement for stone extraction. Supplied
Medicine Products: